Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168867 · ClinicalTrials.gov registry record · NA
Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)
A NA study of Type 1 Diabetes Mellitus, sponsored by Wayne State University.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
- 7
- Study locations
NCT03168867: Completed NA study of Type 1 Diabetes Mellitus, sponsored by Wayne State University.
NCT03168867 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Wayne State University. The registered enrollment target is 149 participants, below the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (13% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168867, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of the study is to conduct a multicenter, randomized effectiveness trial of The 3Ms. The proposed study will use an effectiveness-implementation "Hybrid 1" design. In this design, the primary goal is to determine whether an intervention works in a real-world setting, but the design also answers secondary questions such as the relationship between treatment dose and treatment outcome and what factors affect the actual delivery of the intervention in the clinics (staff burden, workflow interference etc).
Primary Outcome
Hemoglobin A1c (HbA1c)
Conditions Studied
Interventions
- BEHAVIORAL The 3Ms Intervention
Study Locations (7)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- Children's Hospital University of Illinois - Chicago
- UChicago Medicine Comer Children's Hospital - Chicago
- La Rabida Children's Hospital - Chicago
Michigan
- Children's Hospital of Michigan - Detroit
- Ascension St. John Children's Hospital - Detroit
- William Beaumont Children's Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2021-08-03 |
| Phase | NA |
What the finished NCT03168867 record still lists
NCT03168867 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 171-participant average among 112 other Type 1 Diabetes Mellitus trials with a reported enrollment target (13% lower).
The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which The 3Ms Intervention is the first listed.
NCT03168867 lists 7 locations in 2 states (Illinois, Michigan).
Frequently Asked Questions
What is clinical trial NCT03168867 about?
NCT03168867 is a clinical study titled "Effectiveness Trial of an E-Health Intervention To Support Diabetes Care in Minority Youth (3Ms)". The purpose of the study is to conduct a multicenter, randomized effectiveness trial of The 3Ms. The proposed study will use an effectiveness-implementation "Hybrid 1" design. In this design, the primary goal is to determine whether an intervention works in a real-world setting, but the design also ...
What is the current status of trial NCT03168867?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2017-09-25. Estimated completion is 2021-08-03.
What conditions does trial NCT03168867 study?
This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT03168867?
The interventions under investigation include: The 3Ms Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03168867?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03168867 being conducted?
This trial has 7 study locations across Illinois, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03168867's enrollment target sits among peer trials
149 22nd of 112 higher than 91 of 112 other Type 1 Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
RECRUITING · NA
-
Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)
RECRUITING · NA
-
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
RECRUITING · NA
-
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
RECRUITING · NA
-
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
RECRUITING · NA
-
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI